SCHEMBL9914927

SCHEMBL9914927

C=C(C)/N=C\N(N)c1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)CCCCC)CC3)c[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.45
CYP3A4 P08684 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
KCNH2 Q12809 1/20 0.40
P2RY12 Q9H244 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
GNAI3 P08754 1/20 0.31
GNAI1 P63096 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9914931 0.90 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914923 0.88 CYP2C9 (0.43) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12101652 0.80 CYP2C9 (0.39) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12101629 0.79 CYP2C9 (0.36) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12513521 0.78 CYP2C9 (0.45) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL15273583 0.76 CYP3A4 (0.69) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL15273638 0.76 CYP3A4 (0.69) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL14385717 0.75 CYP2C9 (0.44) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914925 0.71 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914946 0.71 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012075235-A1 ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-06-07 WO disclosed